"","X","study","condition_arm1","condition_arm2","multi_arm1","multi_arm2","is.multiarm","no.arms","outcome_type","sample","instrument","rating","time","time_weeks","mean_arm1","sd_arm1","n_arm1","mean_arm2","sd_arm2","n_arm2","mean_change_arm1","mean_change_arm2","sd_change_arm1","sd_change_arm2","n_change_arm1","n_change_arm2","event_arm1","event_arm2","totaln_arm1","totaln_arm2","precalc_g","precalc_g_se","precalc_log_rr","precalc_log_rr_se","baseline_mean_arm1","baseline_sd_arm1","baseline_n_arm1","baseline_mean_arm2","baseline_sd_arm2","baseline_n_arm2","attr_arm1","attr_arm2","year","comorbid_mental","format","n_sessions_arm1","country","age_group","mean_age","percent_women","percent_adm_arm1","percent_adm_arm2","recruitment","target_group","domain.1","domain.2","domain.3","domain.4","domain.5","ROB","full_ref","rob",".id",".g",".g_se",".log_rr",".log_rr_se",".event_arm1",".event_arm2",".totaln_arm1",".totaln_arm2"
"1",1,"Alcolado,2016","ct","wl",NA,NA,0,2,"other stat","NR","voci","sr","post","3",NA,NA,12,NA,NA,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.66,0.48,NA,NA,NA,NA,12,NA,NA,12,"NR","NR",2016,"n","ind","2","N America","adul",33,"0.71","NR","NR","com","adul","Some concerns","Some concerns","High risk","Low risk","Some concerns","2","Alcolado, G. M., & Radomsky, A. S. (2016). A novel cognitive intervention for compulsive checking: Targeting maladaptive beliefs about memory. Journal of Behavior Therapy and Experimental Psychiatry, 53, 75-83. ",2,"Alcolado_2016_otherstat_voci_post_3_sr_ct_wl_NA_NA",1.66,0.48,NA,NA,NA,NA,NA,NA
"2",2,"Anderson,2007","cbt","wl","cbt(grp)","wl",1,3,"msd","co","ybocs","cr","post","10",18.1,7.7,20,23.5,6.4,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.4","7.3",25,"24.1","5.0999999999999996",17,"5","3",2007,"n","grp","9","au","adul",35,"0.74","0.65","0.56999999999999995","clin","adul","Some concerns","Low risk","Some concerns","High risk","Some concerns","2","Anderson, R. A., & Rees, C. S. (2007). Group versus individual cognitive-behavioural treatment for obsessive-compulsive disorder: a controlled trial. Behav       Res Ther, 45(1), 123-137. ",2,"Anderson_2007_msd_ybocs_post_10_cr_cbt_wl_cbt(grp)_wl",0.73225918698949,0.360138975632893,NA,NA,NA,NA,NA,NA
"3",3,"Anderson,2007","cbt","wl","cbt(ind)","wl",1,3,"msd","co","ybocs","cr","post","10",16.7,6.8,17,23.5,6.4,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24","6.2",21,"24.1","5.0999999999999996",17,"4","3",2007,"n","ind","10","au","adul",33,"0.66","0.65","0.56999999999999995","clin","adul","Some concerns","Low risk","Some concerns","High risk","Some concerns","2","Anderson, R. A., & Rees, C. S. (2007). Group versus individual cognitive-behavioural treatment for obsessive-compulsive disorder: a controlled trial. Behav       Res Ther, 45(1), 123-137. ",2,"Anderson_2007_msd_ybocs_post_10_cr_cbt_wl_cbt(ind)_wl",0.999838640832884,0.383733336178153,NA,NA,NA,NA,NA,NA
"4",4,"Andersson,2012","cbt","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","10",12.94,6.26,49,18.88,4.18,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.42","4.59",50,"20.8","4.04",51,"2","0",2012,"n","gsh","7","eu","adul",34,"0.66","0.2","0.25","com","adul","Low risk","Some concerns","Low risk","Low risk","Some concerns","2","Andersson, E., Enander, J., Andrén, P., Hedman, E., Ljótsson, B., Hursti, T., . . . Rück, C. (2012). Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med, 42(10), 2193-2203.",2,"Andersson_2012_msd_ybocs_post_10_cr_cbt_psychologicalplacebo_NA_NA",1.11179118015687,0.215156564378041,NA,NA,NA,NA,NA,NA
"5",5,"Andersson,2012","cbt","psychological placebo",NA,NA,0,2,"msd","co","oci-r","cr","post","10",12.5,10.15,48,19.22,11.52,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.36","13.25",50,"19.86","9.48",51,"2","0",2012,"n","gsh","7","eu","adul",34,"0.66","0.2","0.25","com","adul","Low risk","Some concerns","Low risk","Low risk","Some concerns","2","Andersson, E., Enander, J., Andrén, P., Hedman, E., Ljótsson, B., Hursti, T., . . . Rück, C. (2012). Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med, 42(10), 2193-2203.",2,"Andersson_2012_msd_oci-r_post_10_cr_cbt_psychologicalplacebo_NA_NA",0.612985614388741,0.205836533574938,NA,NA,NA,NA,NA,NA
"6",6,"Barrett,2003","cbt","wl",NA,NA,1,2,"other stat","NR","nimh-gocs","cr","post","14",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.59,0.67,NA,NA,NA,NA,12,NA,NA,12,"NR","NR",2003,"n","FB","14","au","child",11,"0.42","NR","NR","com","child and adol","Some concerns","High risk","High risk","High risk","Some concerns","2","Barrett, P., Healy, L., & March, J. S. (2003). Behavioral avoidance test for childhood obsessive-compulsive disorder: A home-based observation. American Journal of Psychotherapy, 57(1), 80-100. ",2,"Barrett_2003_otherstat_nimh-gocs_post_14_cr_cbt_wl_NA_NA",3.59,0.67,NA,NA,NA,NA,NA,NA
"7",7,"Barrett,2003","cbt","wl",NA,NA,1,2,"other stat","NR","cy-bocs","cr","post","14",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.58,0.56,NA,NA,NA,NA,12,NA,NA,12,"NR","NR",2003,"n","FB","14","au","child",11,"0.42","NR","NR","com","child and adol","Some concerns","High risk","High risk","High risk","Some concerns","2","Barrett, P., Healy, L., & March, J. S. (2003). Behavioral avoidance test for childhood obsessive-compulsive disorder: A home-based observation. American Journal of Psychotherapy, 57(1), 80-100. ",2,"Barrett_2003_otherstat_cy-bocs_post_14_cr_cbt_wl_NA_NA",2.58,0.56,NA,NA,NA,NA,NA,NA
"8",8,"Barrett,2004","cbt","wl","cbft(ind)","wl",1,3,"msd","co","nimh-gocs","cr","post","14",3.5,2.3,24,9,2,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"8.7899999999999991","1.62",24,"8.67","1.81",24,"NR","NR",2004,"n","FB","14","au","child",11,"0.48","0.13","0.21","com","child and adol","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62. ",2,"Barrett_2004_msd_nimh-gocs_post_14_cr_cbt_wl_cbft(ind)_wl",2.51010128308008,0.388806653187636,NA,NA,NA,NA,NA,NA
"9",9,"Barrett,2004","cbt","wl","cbft(grp)","wl",1,3,"msd","co","nimh-gocs","cr","post","14",3.31,2.16,29,9,2,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"8.83","1.37",29,"8.67","1.81",24,"NR","NR",2004,"n","FB","14","au","child",12,"0.51","0.31","0.21","com","child and adol","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62. ",2,"Barrett_2004_msd_nimh-gocs_post_14_cr_cbt_wl_cbft(grp)_wl",2.68307514784552,0.382251495889957,NA,NA,NA,NA,NA,NA
"10",10,"Barrett,2004","cbt","wl","cbft(ind)","wl",1,3,"msd","co","cy-bocs","cr","post","14",8.36,6.93,22,24.04,4.14,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.64","4.3",24,"22.95","5.49",24,"NR","NR",2004,"n","FB","14","au","child",11.25,"0.48","0.13","0.21","com","child and adol","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62. ",2,"Barrett_2004_msd_cy-bocs_post_14_cr_cbt_wl_cbft(ind)_wl",2.72945022874709,0.413458328762379,NA,NA,NA,NA,NA,NA
"11",11,"Barrett,2004","cbt","wl","cbft(grp)","wl",1,3,"msd","co","cy-bocs","cr","post","14",8.28,7.33,29,24.04,4.14,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.38","5.62",29,"22.95","5.49",24,"NR","NR",2004,"n","FB","14","au","child",12.4,"0.51","0.31","0.21","com","child and adol","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62. ",2,"Barrett_2004_msd_cy-bocs_post_14_cr_cbt_wl_cbft(grp)_wl",2.54481510116887,0.372949268332186,NA,NA,NA,NA,NA,NA
"12",12,"Bolton-Perrin,2008","erp","wl",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","7",13.39,8.22,10,21.61,8.22,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24","4.78",10,"22","8.25",10,"2","0",2008,"n","ind","9","uk","adol",13,"0.3","0","0","clin","adol","Low risk","Low risk","High risk","High risk","Some concerns","2","Bolton, D., & Perrin, S. (2008). Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. J Behav Ther Exp Psychiatry, 39(1), 11-22. ",2,"Bolton-Perrin_2008_msd_cy-bocs_post_7_cr_erp_wl_NA_NA",0.957746478873239,0.474341649025257,NA,NA,NA,NA,NA,NA
"13",13,"Bolton,2011","cbt","wl","cbt(full)","wl",1,3,"msd","itt","cy-bocs","cr","post","12",9.5,8,36,23.3,8.3,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.3","5",36,"24.2","5",24,"2","3",2011,"n","ind","12","uk","adol",15,"0.56000000000000005","0.11","0.21","clin","adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278. ",2,"Bolton_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt(full)_wl",1.6773755990675,0.305797470613576,NA,NA,NA,NA,NA,NA
"14",14,"Bolton,2011","cbt","wl","cbt(full)","wl",1,3,"msd","itt","oci","sr","post","12",21.6,22.8,36,67.8,31.3,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"67.900000000000006","31.3",36,"68.400000000000006","32.9",24,"2","3",2011,"n","ind","12","uk","adol",15,"0.56000000000000005","0.11","0.21","clin","adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278. ",2,"Bolton_2011_msd_oci_post_12_sr_cbt_wl_cbt(full)_wl",1.72082295047114,0.307855550365248,NA,NA,NA,NA,NA,NA
"15",15,"Bolton,2011","cbt","wl","cbt(brief)","wl",1,3,"msd","itt","cy-bocs","cr","post","12",13,9.6,36,23.3,8.3,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22","6.9",36,"24.2","5",24,"2","3",2011,"n","ind","5","uk","adol",14,"0.6","0.06","0.21","clin","adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278. ",2,"Bolton_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt(brief)_wl",1.1163448939104,0.283027831873959,NA,NA,NA,NA,NA,NA
"16",16,"Bolton,2011","cbt","wl","cbt(brief)","wl",1,3,"msd","itt","oci","sr","post","12",36.9,38.4,36,67.8,31.3,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"68.099999999999994","36.200000000000003",36,"68.400000000000006","32.9",24,"2","3",2011,"n","ind","5","uk","adol",14,"0.6","0.06","0.21","clin","adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278. ",2,"Bolton_2011_msd_oci_post_12_sr_cbt_wl_cbt(brief)_wl",0.85302511554768,0.275079683795284,NA,NA,NA,NA,NA,NA
"17",17,"Braga,2016","cbt","wl",NA,NA,0,2,"msd","co","ybocs","cr","post","12",14.1,8.4,61,23.5,6.4,42,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"27.4","5.8",61,"26.2","5",42,"14","33",2016,"n","grp","12","eu","adul",43,"0.67","0.53","0.41","com","adul","Some concerns","High risk","High risk","High risk","Some concerns","2","Braga, D. T., Abramovitch, A., Fontenelle, L. F., Ferrão, Y. A., Gomes, J. B., Vivan, A. S., . . . Cordioli, A. V. (2016). Neuropsychological predictors of treatment response to cognitive behavioral group therapy in obsessive-compulsive disorder. Depress Anxiety, 33(9), 848-861.",2,"Braga_2016_msd_ybocs_post_12_cr_cbt_wl_NA_NA",1.21938546830796,0.218012860997133,NA,NA,NA,NA,NA,NA
"18",18,"Challacombe,2017","cbt","cau",NA,NA,0,2,"msd","co","ybocs","cr","post","26",13.71,8.95,17,20.88,6.34,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.82","5.19",17,"24.47","5.81",17,"0","1",2017,"n","TI","4","uk","adul",33,"1","0.41","0.64","com","ppd","Some concerns","Low risk","Low risk","Low risk","Some concerns","2","Challacombe, F. L., Salkovskis, P. M., Woolgar, M., Wilkinson, E. L., Read, J., & Acheson, R. (2017). A pilot randomized controlled trial of time-intensive cognitive–behaviour therapy for postpartum obsessive–compulsive disorder: Effects on maternal symptoms, mother–infant interactions and attachment. Psychological Medicine, 47(8), 1478-1488. R ",2,"Challacombe_2017_msd_ybocs_post_26_cr_cbt_cau_NA_NA",0.897159250798138,0.366246221569807,NA,NA,NA,NA,NA,NA
"19",19,"Challacombe,2017","cbt","cau",NA,NA,0,2,"msd","co","oci-r","sr","post","26",26.18,23.8,17,52.23,30.96,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"53.88","23.11",17,"61.82","27.95",17,"0","1",2017,"n","TI","4","uk","adul",33,"1","0.41","0.64","com","ppd","Some concerns","Low risk","Low risk","Low risk","Some concerns","2","Challacombe, F. L., Salkovskis, P. M., Woolgar, M., Wilkinson, E. L., Read, J., & Acheson, R. (2017). A pilot randomized controlled trial of time-intensive cognitive–behaviour therapy for postpartum obsessive–compulsive disorder: Effects on maternal symptoms, mother–infant interactions and attachment. Psychological Medicine, 47(8), 1478-1488. R ",2,"Challacombe_2017_msd_oci-r_post_26_sr_cbt_cau_NA_NA",0.924225403702928,0.367316002964705,NA,NA,NA,NA,NA,NA
"20",20,"Cordioli,2003","cbt","wl",NA,NA,0,2,"msd","itt","ybocs","cr","post","12",15.1,7.8,23,23.2,5.5,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.7","4.9000000000000004",23,"24.7","5.2",24,"1","1",2003,"n","grp","12","oth","adul",37,"0.51","0.43","0.46","com","adul","Low risk","Some concerns","Low risk","Low risk","Some concerns","2","Cordioli, A. V., Heldt, E., Bochi, D. B., Margis, R., De Sousa, M. B., Tonello, J. F., . . . Kapczinski, F. (2003). Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychosomatics, 72(4), 211-216. ",2,"Cordioli_2003_msd_ybocs_post_12_cr_cbt_wl_NA_NA",1.18454314880034,0.317151680970298,NA,NA,NA,NA,NA,NA
"21",21,"Cordioli,2003","cbt","wl",NA,NA,0,2,"msd","itt","nimh-oc","cr","post","12",5.2,2.6,23,8,1.8,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"8.6","1.3",23,"8","1.5",24,"1","1",2003,"n","grp","12","oth","adul",37,"0.51","0.43","0.46","com","adul","Low risk","Some concerns","Low risk","Low risk","Some concerns","2","Cordioli, A. V., Heldt, E., Bochi, D. B., Margis, R., De Sousa, M. B., Tonello, J. F., . . . Kapczinski, F. (2003). Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychosomatics, 72(4), 211-216. ",2,"Cordioli_2003_msd_nimh-oc_post_12_cr_cbt_wl_NA_NA",1.23605534841459,0.319307514199987,NA,NA,NA,NA,NA,NA
"22",22,"Fals-Stewart-Schafer,1992","erp","psychological placebo",NA,NA,0,2,"msd","co","nimh-oc","cr","post","6",8.1,3.1,19,13,3.6,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"14.2","3.6",20,"13.8","3.5",20,"1","2",1992,"y","ind","18","N America","adul",33,"0.26","NR","NR","oth","oth","Some concerns","High risk","Some concerns","High risk","Some concerns","2","Fals-Stewart, W., & Schafer, J. (1992). The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat, 9(4), 365-370. ",2,"Fals-Stewart-Schafer_1992_msd_nimh-oc_post_6_cr_erp_psychologicalplacebo_NA_NA",1.43018506037417,0.370217468547198,NA,NA,NA,NA,NA,NA
"23",23,"Fals-Stewart-Schafer,1992","erp","psychological placebo",NA,NA,0,2,"msd","co","nimh-oc","cr","fu1","58",7.1,2.5,19,9.9,2.2,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"14.2","3.6",19,"13.8","3.5",18,"1","2",1992,"y","ind","18","N America","adul",33,"0.26","NR","NR","oth","oth","Some concerns","High risk","Some concerns","High risk","Some concerns","2","Fals-Stewart, W., & Schafer, J. (1992). The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat, 9(4), 365-370. ",2,"Fals-Stewart-Schafer_1992_msd_nimh-oc_fu1_58_cr_erp_psychologicalplacebo_NA_NA",1.16129880966245,0.35668550801861,NA,NA,NA,NA,NA,NA
"24",24,"Foa,2005","erp","pill placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","12",11,7.9,21,22.2,6.4,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.6","4.8",29,"25","4",26,"16","12",2005,"n","ind","15","N America","adul",34,"0.51","NR","NR","com","adul","Some concerns","Low risk","High risk","Low risk","Some concerns","2","Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., . . . Tu, X. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 162(1), 151-161. ",2,"Foa_2005_msd_ybocs_post_12_cr_erp_pillplacebo_NA_NA",1.52368552314169,0.356454879415902,NA,NA,NA,NA,NA,NA
"25",25,"Foa,2005","erp","pill placebo",NA,NA,0,2,"msd","co","nimh-oc","cr","post","12",4.3,3,21,8.8,1.8,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"9,1","1,6",29,"8,9","1,8",26,"16","12",2005,"n","ind","15","N America","adul",34,"0.51","NR","NR","com","adul","Some concerns","Low risk","High risk","Low risk","Some concerns","2","Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., . . . Tu, X. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 162(1), 151-161. ",2,"Foa_2005_msd_nimh-oc_post_12_cr_erp_pillplacebo_NA_NA",1.77314477482885,0.370795716114983,NA,NA,NA,NA,NA,NA
"26",26,"Freeman,2008","cbt","psychological placebo",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","14",14.45,8.16,22,17.1,7.57,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.95","3.84",22,"22","4.5199999999999996",20,"1","1",2008,"n","FB","12","N America","child",7,"0.56999999999999995","NR","NR","com","child","Some concerns","Low risk","Low risk","Low risk","Some concerns","2","Freeman, J. B., Garcia, A. M., Coyne, L., Ale, C., Przeworski, A., Himle, M., . . . Leonard, H. L. (2008). Early childhood OCD: Preliminary findings from a family-based cognitive-behavioral approach. Journal of the American Academy of Child & Adolescent Psychiatry, 47(5), 593-602. ",2,"Freeman_2008_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA",0.329729293365413,0.311125549326634,NA,NA,NA,NA,NA,NA
"27",27,"Freeman,2014","cbt","psychological placebo",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","14",12.3,5.5,63,19.67,5.6,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.13","4.46",63,"25.97","3.98",64,"2","6",2014,"n","FB","12","N America","child",7,"0.53","0.95","0.06","com","child","Some concerns","Low risk","Some concerns","Low risk","Low risk","2","Freeman, J., Sapyta, J., Garcia, A., Compton, S., Khanna, M., Flessner, C., . . . Benito, K. (2014). Family-based treatment of early childhood obsessive-compulsive disorder: The Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)—A randomized clinical trial. JAMA psychiatry, 71(6), 689-698. ",2,"Freeman_2014_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA",1.31979572246152,0.19605851809427,NA,NA,NA,NA,NA,NA
"28",28,"Freeston,1997","cbt","wl",NA,NA,0,2,"msd","itt","ybocs","cr","post","16",12.2,9.6,15,22,6,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.1","5",15,"21.2","6",14,"NR","NR",1997,"n","ind","26","N America","adul",36,"0.45","0.33","0.36","oth","adul","Some concerns","Low risk","High risk","High risk","Some concerns","2","Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997). Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol, 65(3), 405-413. ",2,"Freeston_1997_msd_ybocs_post_16_cr_cbt_wl_NA_NA",1.18037075645062,0.404379889979271,NA,NA,NA,NA,NA,NA
"29",29,"Freeston,1997","cbt","wl",NA,NA,0,2,"msd","itt","padua","sr","post","16",54.7,32.9,15,83.9,35.6,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"71.5","31.4",15,"87.1","43.4",14,"NR","NR",1997,"n","ind","26","N America","adul",36,"0.45","0.33","0.36","oth","adul","Some concerns","Low risk","High risk","High risk","Some concerns","2","Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997). Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol, 65(3), 405-413. ",2,"Freeston_1997_msd_padua_post_16_sr_cbt_wl_NA_NA",0.82921792403291,0.388129193222705,NA,NA,NA,NA,NA,NA
"30",30,"Gomes,2016","cbt","wl",NA,NA,0,2,"msd","NR","ybocs","cr","post","13",13.8,8.54,46,24.7,5.37,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"27.3","5.7",52,"26.4","5.43",46,"6","7",2016,"n","FB","12","oth","adul",41,"0.62","0.5","0.59","com","adul","Low risk","Some concerns","Some concerns","High risk","Some concerns","2","Gomes, J. B., Cordioli, A. V., Bortoncello, C. F., Braga, D. T., Gonçalves, F., & Heldt, E. (2016). Impact of cognitive-behavioral group therapy for obsessive-compulsive disorder on family accommodation: A randomized clinical trial. Psychiatry Res, 246, 70-76. ",2,"Gomes_2016_msd_ybocs_post_13_cr_cbt_wl_NA_NA",1.48726101968062,0.246233023659058,NA,NA,NA,NA,NA,NA
"31",31,"Gomes,2016","cbt","wl",NA,NA,0,2,"msd","NR","oci-r","sr","post","13",15.8,14.04,46,34.5,15.05,39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"34.5","16",52,"33.9","13.6",46,"6","7",2016,"n","FB","12","oth","adul",41,"0.62","0.5","0.59","com","adul","Low risk","Some concerns","Some concerns","High risk","Some concerns","2","Gomes, J. B., Cordioli, A. V., Bortoncello, C. F., Braga, D. T., Gonçalves, F., & Heldt, E. (2016). Impact of cognitive-behavioral group therapy for obsessive-compulsive disorder on family accommodation: A randomized clinical trial. Psychiatry Res, 246, 70-76. ",2,"Gomes_2016_msd_oci-r_post_13_sr_cbt_wl_NA_NA",1.27698564376067,0.23905801685151,NA,NA,NA,NA,NA,NA
"32",32,"Greist,2002","erp","psychological placebo","erp(ind)","psychological placebo",1,3,"msd","NR","ybocs","sr","post","10",17.6,6.2,55,24.1,6.7,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.2","4.5999999999999996",55,"25.8","5.0999999999999996",66,"14","9",2002,"n","ind","11","N America","adul",39,"0.42","NR","NR","com","adul","Some concerns","Low risk","High risk","Low risk","Some concerns","2","Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., . . . Clary, C. M. (2002). Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry, 63(2), 138-145. ",2,"Greist_2002_msd_ybocs_post_10_sr_erp_psychologicalplacebo_erp(ind)_psychologicalplacebo",0.997075203544857,0.193633198907312,NA,NA,NA,NA,NA,NA
"33",33,"Greist,2002","erp","psychological placebo","erp(ush)","psychological placebo",1,3,"msd","co","ybocs","sr","post","10",19,7.2,55,24.1,6.7,66,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.6","4.3",55,"25.8","5.0999999999999996",66,"19","9",2002,"n","ush","9","oth","adul",39,"0.42","NR","NR","com","adul","Some concerns","Low risk","High risk","Low risk","Some concerns","2","Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., . . . Clary, C. M. (2002). Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry, 63(2), 138-145. ",2,"Greist_2002_msd_ybocs_post_10_sr_erp_psychologicalplacebo_erp(ush)_psychologicalplacebo",0.731139038820659,0.188601287700994,NA,NA,NA,NA,NA,NA
"34",34,"Hauschildt,2016","3rd","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","post","4",19.3,6.36,64,19.98,7.03,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.56","6.58",64,"21.45","6.42",64,"14","10",2016,"n","ush","NR","eu","adul",39,"0.67","0.38","0.3","com","adul","Some concerns","Low risk","Some concerns","Low risk","Some concerns","2","Hauschildt, M., Schröder, J., & Moritz, S. (2016). Randomized-controlled trial on a novel (meta-) cognitive self-help approach for obsessive-compulsive disorder (“myMCT”). Journal of Obsessive-Compulsive and Related Disorders, 10, 26-34.",2,"Hauschildt_2016_msd_ybocs_post_4_cr_3rd_psychologicalplacebo_NA_NA",0.100836404294198,0.176890352273699,NA,NA,NA,NA,NA,NA
"35",35,"Hauschildt,2016","3rd","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","fu1","26",17.96,6.33,64,17.55,7.88,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.56","6.58",64,"21.45","6.42",64,"20","10",2016,"n","ush","NR","eu","adul",39,"0.67","0.38","0.3","com","adul","Some concerns","Low risk","Some concerns","Low risk","Some concerns","2","Hauschildt, M., Schröder, J., & Moritz, S. (2016). Randomized-controlled trial on a novel (meta-) cognitive self-help approach for obsessive-compulsive disorder (“myMCT”). Journal of Obsessive-Compulsive and Related Disorders, 10, 26-34.",2,"Hauschildt_2016_msd_ybocs_fu1_26_cr_3rd_psychologicalplacebo_NA_NA",-0.0570234405810906,0.176813050214649,NA,NA,NA,NA,NA,NA
"36",36,"Hawley,2021","3rd","wl",NA,NA,0,2,"other stat","itt","ybocs","sr","post","8",NA,NA,36,NA,NA,35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.33,0.24,NA,NA,NA,NA,36,NA,NA,35,"1","1",2021,"n","ush","56","oth","adul",26,"NR","0.37","0.31","clin","adul","Some concerns","Low risk","Low risk","Low risk","Some concerns","2","Hawley, L. L., Rector, N. A., DaSilva, A., Laposa, J. M., & Richter, M. A. (2021). Technology supported mindfulness for obsessive compulsive disorder: Self-reported mindfulness and EEG correlates of mind wandering. Behaviour Research and Therapy, 136, 103757.",2,"Hawley_2021_otherstat_ybocs_post_8_sr_3rd_wl_NA_NA",0.33,0.24,NA,NA,NA,NA,NA,NA
"37",37,"Herbst,2014","erp","wl",NA,NA,0,2,"msd","itt","ybocs","sr","post","8",14.44,5.9,16,19.33,6.46,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"20.25","6.71",16,"20","5.4",18,"0","3",2014,"n","gsh","14","eu","adul",36,"0.65","0.26","0.26","com","adul","Some concerns","Low risk","Some concerns","Low risk","Some concerns","2","Herbst, N., Voderholzer, U., Thiel, N., Schaub, R., Knaevelsrud, C., Stracke, S., . . . Külz, A. K. (2014). No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder. Psychother Psychosom, 83(3), 165-175. ",2,"Herbst_2014_msd_ybocs_post_8_sr_erp_wl_NA_NA",0.769607389856221,0.35664035807798,NA,NA,NA,NA,NA,NA
"38",38,"Herbst,2014","erp","wl",NA,NA,0,2,"msd","itt","oci-r","sr","post","8",15.56,8.93,16,24.11,10.84,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26","10.3",16,"25.89","9.99",18,"0","3",2014,"n","gsh","14","eu","adul",36,"0.65","0.26","0.26","com","adul","Some concerns","Low risk","Some concerns","Low risk","Some concerns","2","Herbst, N., Voderholzer, U., Thiel, N., Schaub, R., Knaevelsrud, C., Stracke, S., . . . Külz, A. K. (2014). No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder. Psychother Psychosom, 83(3), 165-175. ",2,"Herbst_2014_msd_oci-r_post_8_sr_erp_wl_NA_NA",0.835617136856314,0.358924641165612,NA,NA,NA,NA,NA,NA
"39",39,"Khodarahimi,2009","erp","wl","erp","wl",1,3,"msd","co","ybocs","sr","post","6",5.58,10.69,20,36.45,10.02,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.200000000000003","8.5399999999999991",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_post_6_sr_erp_wl_erp_wl",2.92041212150507,0.459321153345249,NA,NA,NA,NA,NA,NA
"40",40,"Khodarahimi,2009","erp","wl","erp","wl",1,3,"msd","co","ybocs","sr","fu1","13",5.6,9.35,20,35.25,10.24,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.200000000000003","8.5399999999999991",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_fu1_13_sr_erp_wl_erp_wl",2.9638573274075,0.462927991266034,NA,NA,NA,NA,NA,NA
"41",41,"Khodarahimi,2009","erp","wl","erp","wl",1,3,"msd","co","ybocs","sr","fu2","26",4.3,11.04,20,35.85,10.15,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.200000000000003","8.5399999999999991",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_fu2_26_sr_erp_wl_erp_wl",2.91608677418479,0.458963438821394,NA,NA,NA,NA,NA,NA
"42",42,"Khodarahimi,2009","other psy","wl","other psy","wl",1,3,"msd","co","ybocs","sr","post","6",6.4,9.43,20,36.45,10.02,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.1","8.81",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_post_6_sr_otherpsy_wl_otherpsy_wl",3.02719164054178,0.468230225763666,NA,NA,NA,NA,NA,NA
"43",43,"Khodarahimi,2009","other psy","wl","other psy","wl",1,3,"msd","co","ybocs","sr","fu1","13",4.03,9.03,20,35.25,10.24,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.1","8.81",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_fu1_13_sr_otherpsy_wl_otherpsy_wl",3.16965108754873,0.480339908314451,NA,NA,NA,NA,NA,NA
"44",44,"Khodarahimi,2009","other psy","wl","other psy","wl",1,3,"msd","co","ybocs","sr","fu2","26",3,8.45,20,35.85,10.15,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"37.1","8.81",20,"36.4","10.11",20,"NR","NR",2009,"n","ind","12","oth","adul",25,"0","0","0","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207. ",2,"Khodarahimi_2009_msd_ybocs_fu2_26_sr_otherpsy_wl_otherpsy_wl",3.44771036101454,0.504646959586297,NA,NA,NA,NA,NA,NA
"45",45,"Kobayashi,2020","erp","cau",NA,NA,0,2,"msd","itt","ybocs","cr","post","16",16.62,6.19,9,26.38,4.72,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.67","5.5",9,"27.75","3.24",8,"1","1",2020,"n","FB","24","oth","adul",30,"0.47","0.89","0.88","clin","adul","Low risk","Low risk","Some concerns","Low risk","Low risk","1","Kobayashi, Y., Kanie, A., Nakagawa, A., Takebayashi, Y., Shinmei, I., Nakayama, N., . . . Mimura, M. (2020). An evaluation of family-based treatment for OCD in Japan: a pilot randomized controlled trial. Frontiers in Psychiatry, 10, 932. ",1,"Kobayashi_2020_msd_ybocs_post_16_cr_erp_cau_NA_NA",1.66834594937256,0.571822758676799,NA,NA,NA,NA,NA,NA
"46",46,"Kyrios,2018","cbt","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","post","12",15.86,5.65,89,19.15,6.45,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.44","5.36",89,"22.13","5.73",90,"37","27",2018,"n","gsh","12","au","adul",33,"0.66","0.71","0.75","com","adul","Low risk","Low risk","High risk","Low risk","High risk","2","Kyrios, M., Ahern, C., Fassnacht, D. B., Nedeljkovic, M., Moulding, R., & Meyer, D. (2018). Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial. J Med Internet Res, 20(8), e242. ",2,"Kyrios_2018_msd_ybocs_post_12_cr_cbt_psychologicalplacebo_NA_NA",0.54011366654452,0.152213317234354,NA,NA,NA,NA,NA,NA
"47",47,"Launes,2019","erp","wl","erp(intensive)","wl",1,3,"msd","co","ybocs","cr","post","12",10.9,4.35,16,27.32,4.14,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.75","4.2300000000000004",16,"26.88","3.93",15,"0","1",2019,"n","oth","NR","eu","adul",32,"0.78","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_ybocs_post_12_cr_erp_wl_erp(intensive)_wl",3.76281567892582,0.608220300460644,NA,NA,NA,NA,NA,NA
"48",48,"Launes,2019","erp","wl","erp(intensive)","wl",1,3,"msd","co","docs-sf","sr","post","12",13.44,7.08,16,25.24,5.43,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.56","3.81",16,"28.56","6.29",15,"0","1",2019,"n","oth","NR","eu","adul",32,"0.78","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_docs-sf_post_12_sr_erp_wl_erp(intensive)_wl",1.81341424123157,0.43021622542531,NA,NA,NA,NA,NA,NA
"49",49,"Launes,2019","erp","wl","erp(intensive)","wl",1,3,"msd","co","oci-r","sr","post","12",7.94,5.94,16,25.19,13.38,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.69","12.42",16,"27.69","14.42",15,"0","1",2019,"n","oth","NR","eu","adul",32,"0.78","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_oci-r_post_12_sr_erp_wl_erp(intensive)_wl",1.64204979660704,0.418350091315225,NA,NA,NA,NA,NA,NA
"50",50,"Launes,2019","erp","wl","erp(ush)","wl",1,3,"msd","co","ybocs","cr","post","12",24.63,6.18,16,27.32,4.14,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"27.88","4.22",16,"26.88","3.93",15,"0","1",2019,"n","ush","NR","eu","adul",29,"0.75","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_ybocs_post_12_cr_erp_wl_erp(ush)_wl",0.49484458341222,0.365144652773159,NA,NA,NA,NA,NA,NA
"51",51,"Launes,2019","erp","wl","erp(ush)","wl",1,3,"msd","co","docs-sf","sr","post","12",24.63,6.47,16,25.24,5.43,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.69","3.61",16,"28.56","6.29",15,"0","1",2019,"n","ush","NR","eu","adul",29,"0.75","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_docs-sf_post_12_sr_erp_wl_erp(ush)_wl",0.0991712530840601,0.359630235702226,NA,NA,NA,NA,NA,NA
"52",52,"Launes,2019","erp","wl","erp(ush)","wl",1,3,"msd","co","oci-r","sr","post","12",22,13.14,16,25.19,13.38,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"29.25","15.29",16,"27.69","14.42",15,"0","1",2019,"n","ush","NR","eu","adul",29,"0.75","0.25","0.25","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500. ",0,"Launes_2019_msd_oci-r_post_12_sr_erp_wl_erp(ush)_wl",0.234360877625045,0.360694674147815,NA,NA,NA,NA,NA,NA
"53",53,"Lenhard,2017","cbt","wl",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","12",16.97,6.29,33,20.64,4.11,34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23","4.3099999999999996",33,"22.12","3.91",34,"0","1",2017,"n","FB","12","eu","adol",15,"0.46","0.28000000000000003","0.18","com","adol","Low risk","Low risk","Low risk","Low risk","Low risk","0","Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12. ",0,"Lenhard_2017_msd_cy-bocs_post_12_cr_cbt_wl_NA_NA",0.684874807331692,0.25159037260984,NA,NA,NA,NA,NA,NA
"54",54,"Lenhard,2017","cbt","wl",NA,NA,0,2,"msd","itt","choci-r-c","sr","post","12",19.96,7.83,33,24.68,6.93,34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.48","6.72",33,"25.38","7.71",34,"0","1",2017,"n","FB","12","eu","adol",15,"0.46","0.28000000000000003","0.18","com","adol","Low risk","Low risk","Low risk","Low risk","Low risk","0","Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12. ",0,"Lenhard_2017_msd_choci-r-c_post_12_sr_cbt_wl_NA_NA",0.631576922542203,0.250522970763338,NA,NA,NA,NA,NA,NA
"55",55,"Lenhard,2017","cbt","wl",NA,NA,0,2,"msd","itt","choci-r-p","sr","post","12",19.32,9.88,33,25.25,10.04,34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.42","7.56",33,"25.56","8.36",34,"0","1",2017,"n","FB","12","eu","adol",15,"0.46","0.28000000000000003","0.18","com","adol","Low risk","Low risk","Low risk","Low risk","Low risk","0","Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12. ",0,"Lenhard_2017_msd_choci-r-p_post_12_sr_cbt_wl_NA_NA",0.588393533503894,0.249718516924853,NA,NA,NA,NA,NA,NA
"56",56,"Lewin,2014","erp","cau",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","7",12.29,8.61,17,24,4.35,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.47","5.8",17,"24.5","5.68",14,"0","0",2014,"n","FB","12","N America","child",6,"0.28999999999999998","0.06","0.43","clin","child","Some concerns","Low risk","Low risk","Low risk","Some concerns","2","Lewin, A. B., Park, J. M., Jones, A. M., Crawford, E. A., De Nadai, A. S., Menzel, J., . . . Storch, E. A. (2014). Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial. Behav Res Ther, 56, 30-38. ",2,"Lewin_2014_msd_cy-bocs_post_7_cr_erp_cau_NA_NA",1.62288773857863,0.41837587390809,NA,NA,NA,NA,NA,NA
"57",57,"Lindsay,1997","erp","psychological placebo",NA,NA,0,2,"msd","NR","ybocs","cr","post","3",11,3.81,9,25.89,5.8,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.7","4.5599999999999996",9,"24.44","6.98",9,"0","0",1997,"n","ind","15","au","adul",33,"0.67","0.28000000000000003","0.28000000000000003","clin","adul","Some concerns","Some concerns","Low risk","High risk","Some concerns","2","Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139. ",2,"Lindsay_1997_msd_ybocs_post_3_cr_erp_psychologicalplacebo_NA_NA",2.88997937083339,0.691376621759009,NA,NA,NA,NA,NA,NA
"58",58,"Lindsay,1997","erp","psychological placebo",NA,NA,0,2,"msd","NR","moci","sr","post","3",9.56,4.59,9,17.89,4.23,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"17","4.0599999999999996",9,"20.329999999999998","4.0599999999999996",9,"0","0",1997,"n","ind","15","au","adul",33,"0.67","0.28000000000000003","0.28000000000000003","clin","adul","Some concerns","Some concerns","Low risk","High risk","Some concerns","2","Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139. ",2,"Lindsay_1997_msd_moci_post_3_sr_erp_psychologicalplacebo_NA_NA",1.79744517488993,0.566714877735916,NA,NA,NA,NA,NA,NA
"59",59,"Lindsay,1997","erp","psychological placebo",NA,NA,0,2,"msd","NR","padua","sr","post","3",41.44,22.54,9,81.22,35.15,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"84.56","28.36",9,"95.78","39.44",9,"0","0",1997,"n","ind","15","au","adul",33,"0.67","0.28000000000000003","0.28000000000000003","clin","adul","Some concerns","Some concerns","Low risk","High risk","Some concerns","2","Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139. ",2,"Lindsay_1997_msd_padua_post_3_sr_erp_psychologicalplacebo_NA_NA",1.28312885936421,0.522153066262954,NA,NA,NA,NA,NA,NA
"60",60,"Mahoney,2014","cbt","wl",NA,NA,0,2,"msd","co","docs","sr","post","10",19.83,12.71,24,29.11,12.21,35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"34.5","14.83",32,"31.8","11.49",35,"20","7",2014,"n","ush","4","oth","adul",39,"0.6","0.38","0.28999999999999998","com","adul","Low risk","Low risk","High risk","Low risk","Some concerns","2","Mahoney, A. E., Mackenzie, A., Williams, A. D., Smith, J., & Andrews, G. (2014). Internet cognitive behavioural treatment for obsessive compulsive disorder: a randomised controlled trial. Behaviour research and therapy, 63, 99-106.",2,"Mahoney_2014_msd_docs_post_10_sr_cbt_wl_NA_NA",0.737653086079684,0.273813308290186,NA,NA,NA,NA,NA,NA
"61",61,"Mancebo,2021","erp","cau",NA,NA,0,2,"msd","co","ybocs","cr","post","16",20.1,8,25,26,8.7,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.2","4.5",31,"29.2","4.9000000000000004",16,"8","4",2021,"n","oth","22","N America","adul",38,"0.74","0.79","0.67","clin","adul","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Mancebo, M. C., Yip, A. G., Boisseau, C. L., Rasmussen, S. A., & Zlotnick, C. (2021). Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center. Behav Ther, 52(5), 1296-1309.",2,"Mancebo_2021_msd_ybocs_post_16_cr_erp_cau_NA_NA",0.700326154253092,0.343483920094738,NA,NA,NA,NA,NA,NA
"62",62,"Mancebo,2021","erp","cau",NA,NA,0,2,"msd","co","ybocs","cr","fu1","29",23.5,8.1,24,24.5,9.9,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.2","4.5",31,"29.2","4.9000000000000004",16,"9","3",2021,"n","oth","22","N America","adul",38,"0.74","0.79","0.67","clin","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Mancebo, M. C., Yip, A. G., Boisseau, C. L., Rasmussen, S. A., & Zlotnick, C. (2021). Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center. Behav Ther, 52(5), 1296-1309. ",2,"Mancebo_2021_msd_ybocs_fu1_29_cr_erp_cau_NA_NA",0.111009865726887,0.329390307120744,NA,NA,NA,NA,NA,NA
"63",63,"Mancebo,2021","erp","cau",NA,NA,0,2,"msd","co","ybocs","cr","fu2","42",21.8,9.5,19,24.6,10.5,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.2","4,5",31,"29.2","4.9000000000000004",16,"14","7",2021,"n","oth","22","N America","adul",38,"0.74","0.79","0.67","clin","adul","Some concerns","High risk","Low risk","Low risk","Some concerns","2","Mancebo, M. C., Yip, A. G., Boisseau, C. L., Rasmussen, S. A., & Zlotnick, C. (2021). Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center. Behav Ther, 52(5), 1296-1309. ",2,"Mancebo_2021_msd_ybocs_fu2_42_cr_erp_cau_NA_NA",0.276054769332187,0.380634096123952,NA,NA,NA,NA,NA,NA
"64",64,"Mathur,2021","third-wave","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","post","12",13.73,6.73,30,17.51,6.57,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.24","6.57",30,"26.46","5.64",30,"1","2",2021,"n","ind","12","oth","adul",28,"0.33","0.7","0.83","clin","adul","Low risk","Low risk","Low risk","Low risk","Low risk","0","Mathur, S., Sharma, M. P., Balachander, S., Kandavel, T., & Reddy, Y. C. J. (2021). A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder. Journal of Affective Disorders, 282, 58-68. ",0,"Mathur_2021_msd_ybocs_post_12_cr_third-wave_psychologicalplacebo_NA_NA",0.560998367905813,0.263360585186499,NA,NA,NA,NA,NA,NA
"65",65,"Matsumoto,2022","cbt","wl",NA,NA,0,2,"msd","co","ybocs","cr","post","12",14.71,5.65,14,20.87,7.23,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.5","4.1500000000000004",14,"24.31","6.28",16,"1","0",2022,"n","gsh","12","oth","adul",30,"0.56999999999999995","NR","NR","com","adul","Low risk","Some concerns","Low risk","Low risk","Low risk","1","Matsumoto, K., Hamatani, S., Makino, T., Takahashi, J., Suzuki, F., Ida, T., . . . Omori, I. M. (2022). Guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: A multicenter randomized controlled trial in Japan. Internet interventions, 28, 100515. ",1,"Matsumoto_2022_msd_ybocs_post_12_cr_cbt_wl_NA_NA",0.915873173289068,0.385611776072033,NA,NA,NA,NA,NA,NA
"66",66,"Matsumoto,2022","cbt","wl",NA,NA,0,2,"msd","co","oci","sr","post","12",14.71,5.65,14,20.87,7.23,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"22.5","4.1500000000000004",14,"24.31","6.28",16,"1","0",2022,"n","gsh","12","oth","adul",30,"0.56999999999999995","NR","NR","com","adul","Low risk","Some concerns","Low risk","Low risk","Low risk","1","Matsumoto, K., Hamatani, S., Makino, T., Takahashi, J., Suzuki, F., Ida, T., . . . Omori, I. M. (2022). Guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: A multicenter randomized controlled trial in Japan. Internet interventions, 28, 100515. ",1,"Matsumoto_2022_msd_oci_post_12_sr_cbt_wl_NA_NA",0.915873173289068,0.385611776072033,NA,NA,NA,NA,NA,NA
"67",67,"Moritz-Jelinek,2011","ct","wl",NA,NA,0,2,"other stat","itt","ybocs","sr","post","4",NA,NA,40,NA,NA,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.04,0.22,NA,NA,"19.170000000000002","6.92",40,"19.55","6.06",40,"10","1",2011,"n","ush","NR","eu","adul",37,"0.6","0.43","0.61","com","adul","High risk","Low risk","High risk","Low risk","Some concerns","2","Moritz, S., & Jelinek, L. (2011). Further evidence for the efficacy of association splitting as a self‐help technique for reducing obsessive thoughts. Depression and Anxiety, 28(7), 574-581.",2,"Moritz-Jelinek_2011_otherstat_ybocs_post_4_sr_ct_wl_NA_NA",0.04,0.22,NA,NA,NA,NA,NA,NA
"68",68,"Moritz-Jelinek,2011","ct","wl",NA,NA,0,2,"other stat","itt","oci-r","sr","post","4",NA,NA,40,NA,NA,40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.02,0.22,NA,NA,"45.77","12.12",40,"42.54","12.94",40,"10","1",2011,"n","ush","NR","eu","adul",37,"0.6","0.43","0.61","com","adul","High risk","Low risk","High risk","Low risk","Some concerns","2","Moritz, S., & Jelinek, L. (2011). Further evidence for the efficacy of association splitting as a self‐help technique for reducing obsessive thoughts. Depression and Anxiety, 28(7), 574-581.",2,"Moritz-Jelinek_2011_otherstat_oci-r_post_4_sr_ct_wl_NA_NA",0.02,0.22,NA,NA,NA,NA,NA,NA
"69",69,"Moritz,2010","3rd","wl",NA,NA,0,2,"other stat","co","ybocs","sr","post","4",NA,NA,36,NA,NA,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.62,0.24,NA,NA,NA,NA,43,NA,NA,43,"7","5",2010,"n","ush","14","eu","adul",35,"0.67","NR","NR","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Moritz, S., Jelinek, L., Hauschildt, M., & Naber, D. (2010). How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder. Dialogues in clinical neuroscience.",2,"Moritz_2010_otherstat_ybocs_post_4_sr_3rd_wl_NA_NA",0.62,0.24,NA,NA,NA,NA,NA,NA
"70",70,"Moritz,2010","3rd","wl",NA,NA,0,2,"other stat","co","oci-r","sr","post","4",NA,NA,36,NA,NA,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.67,0.24,NA,NA,NA,NA,43,NA,NA,43,"7","5",2010,"n","ush","14","eu","adul",35,"0.67","NR","NR","com","adul","Some concerns","High risk","Some concerns","Low risk","Some concerns","2","Moritz, S., Jelinek, L., Hauschildt, M., & Naber, D. (2010). How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder. Dialogues in clinical neuroscience.",2,"Moritz_2010_otherstat_oci-r_post_4_sr_3rd_wl_NA_NA",0.67,0.24,NA,NA,NA,NA,NA,NA
"71",71,"Moritz,2011","ct","wl",NA,NA,0,2,"other stat","itt","ybocs","sr","post","4",NA,NA,23,NA,NA,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.81,0.31,NA,NA,NA,NA,23,NA,NA,23,"10","2",2011,"n","ush","NR","eu","adul",36,"0.67","0.56000000000000005","0.74","com","adul","High risk","Low risk","High risk","Low risk","Some concerns","2","Moritz, S., Wess, N., Treszl, A., & Jelinek, L. (2011). The attention training technique as an attempt to decrease intrusive thoughts in obsessive–compulsive disorder (OCD): From cognitive theory to practice and back. Journal of Contemporary Psychotherapy, 41, 135-143.",2,"Moritz_2011_otherstat_ybocs_post_4_sr_ct_wl_NA_NA",0.81,0.31,NA,NA,NA,NA,NA,NA
"72",72,"Moritz,2011","ct","wl",NA,NA,0,2,"other stat","itt","oci-r","sr","post","4",NA,NA,23,NA,NA,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.29,0.3,NA,NA,NA,NA,23,NA,NA,23,"10","2",2011,"n","ush","NR","eu","adul",36,"0.67","0.56000000000000005","0.74","com","adul","High risk","Low risk","High risk","Low risk","Some concerns","2","Moritz, S., Wess, N., Treszl, A., & Jelinek, L. (2011). The attention training technique as an attempt to decrease intrusive thoughts in obsessive–compulsive disorder (OCD): From cognitive theory to practice and back. Journal of Contemporary Psychotherapy, 41, 135-143.",2,"Moritz_2011_otherstat_oci-r_post_4_sr_ct_wl_NA_NA",0.29,0.3,NA,NA,NA,NA,NA,NA
"73",73,"Moritz,2018","3rd","wl",NA,NA,0,2,"msd","co","ybocs","sr","post","6",17,8.75,26,20.8,7.22,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.09","5.93",35,"21.74","6.23",35,"9","5",2017,"n","ush","14","eu","adul",39,"0.77","0.56999999999999995","0.63","com","adul","High risk","Low risk","Some concerns","Low risk","Some concerns","2","Moritz, S., Wess, N., Treszl, A., & Jelinek, L. (2011). The attention training technique as an attempt to decrease intrusive thoughts in obsessive–compulsive disorder (OCD): From cognitive theory to practice and back. Journal of Contemporary Psychotherapy, 41, 135-143.",2,"Moritz_2018_msd_ybocs_post_6_sr_3rd_wl_NA_NA",0.470432975091197,0.271711515748757,NA,NA,NA,NA,NA,NA
"74",74,"Moritz,2018","3rd","wl",NA,NA,0,2,"msd","co","oci-r","sr","post","6",40.12,14.03,26,44.8,15.35,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"48.46","12.47",35,"49.03","14.8",35,"9","5",2017,"n","ush","14","eu","adul",39,"0.77","0.56999999999999995","0.63","com","adul","High risk","Low risk","Some concerns","Low risk","Some concerns","2","Moritz, S., Wess, N., Treszl, A., & Jelinek, L. (2011). The attention training technique as an attempt to decrease intrusive thoughts in obsessive–compulsive disorder (OCD): From cognitive theory to practice and back. Journal of Contemporary Psychotherapy, 41, 135-143.",2,"Moritz_2018_msd_oci-r_post_6_sr_3rd_wl_NA_NA",0.312784990992311,0.269616933656926,NA,NA,NA,NA,NA,NA
"75",75,"Nakatani,2005","erp","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","12",12.9,4.9,10,28.4,5.5,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"29.9","3.1",11,"30.5","3.7",9,"1","1",2005,"n","ush","12","oth","adul",34,"0.67","NR","NR","clin","adul","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Nakatani, E., Nakagawa, A., Nakao, T., Yoshizato, C., Nabeyama, M., Kudo, A., ... & Kawamoto, M. (2005). A randomized controlled trial of Japanese patients with obsessive-compulsive disorder–effectiveness of behavior therapy and fluvoxamine. Psychotherapy and Psychosomatics, 74(5), 269-276.",2,"Nakatani_2005_msd_ybocs_post_12_cr_erp_psychologicalplacebo_NA_NA",2.8547080363948,0.688893379213992,NA,NA,NA,NA,NA,NA
"76",76,"Norman,2021","erp","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","12",12.96,7.96,42,21.3,8.16,45,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.1","5.41",42,"27.4","4.59",47,"0","2",2021,"n","ind","12","N America","adul",24,"0.66","0.48","0.42","com","adul and adol","Some concerns","Some concerns","Low risk","Low risk","Low risk","2","Norman, L. J., Mannella, K. A., Yang, H., Angstadt, M., Abelson, J. L., Himle, J. A., . . . Taylor, S. F. (2021). Treatment-Specific Associations Between Brain Activation and Symptom Reduction in OCD Following CBT: A Randomized fMRI Trial. Am J Psychiatry, 178(1), 39-47. ",2,"Norman_2021_msd_ybocs_post_12_cr_erp_psychologicalplacebo_NA_NA",1.02505484540983,0.228426755511978,NA,NA,NA,NA,NA,NA
"77",77,"O'Connor,1999","cbt","no treatment",NA,NA,0,2,"msd","co","ybocs","cr","post","20",13.3,8.6,6,17.5,4,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.5","4",6,"19.3","4.5",6,"NR","NR",1999,"n","ind","20","N America","adul",37,"0.42","NR","NR","clin","adul","High risk","High risk","High risk","Low risk","Some concerns","2","O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study. The Canadian Journal of Psychiatry, 44(1), 64-71. ",2,"O'Connor_1999_msd_ybocs_post_20_cr_cbt_notreatment_NA_NA",0.578066042966244,0.591332333932196,NA,NA,NA,NA,NA,NA
"78",78,"O'Connor,1999","cbt","no treatment",NA,NA,0,2,"msd","co","nimh-oc","cr","post","20",3,3,6,7.2,0.8,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"8.8000000000000007","1.3",6,"6.3","0.8",6,"NR","NR",1999,"n","ind","20","N America","adul",37,"0.42","NR","NR","clin","adul","High risk","High risk","High risk","Low risk","Some concerns","2","O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study. The Canadian Journal of Psychiatry, 44(1), 64-71. ",2,"O'Connor_1999_msd_nimh-oc_post_20_cr_cbt_notreatment_NA_NA",1.76589007239874,0.697010014195887,NA,NA,NA,NA,NA,NA
"79",79,"O'Connor,2006","cbt","pill placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","22",13.3,9.7,10,25.4,3.5,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"28.5","4.5",10,"27.3","4.3",10,"NR","NR",2006,"n","ind","20","N America","adul",37,"0.7","0","0","com","adul","Low risk","High risk","Some concerns","Low risk","Some concerns","2","O'Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pélissier, M. C., Todorov, C., . . . Doucet, P. (2006). Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand, 113(5), 408-419. ",2,"O'Connor_2006_msd_ybocs_post_22_cr_cbt_pillplacebo_NA_NA",1.5892879996522,0.518498323590996,NA,NA,NA,NA,NA,NA
"80",80,"O'Connor,2006","cbt","pill placebo",NA,NA,0,2,"msd","co","padua","sr","post","22",42.6,24.1,10,90.6,45,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"86.8","22.5",10,"96","28.1",10,"NR","NR",2006,"n","ind","20","N America","adul",37,"0.7","0","0","com","adul","Low risk","High risk","Some concerns","Low risk","Some concerns","2","O'Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pélissier, M. C., Todorov, C., . . . Doucet, P. (2006). Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand, 113(5), 408-419. ",2,"O'Connor_2006_msd_padua_post_22_sr_cbt_pillplacebo_NA_NA",1.2736069666587,0.49417497145669,NA,NA,NA,NA,NA,NA
"81",81,"Piacentini,2011","cbt","psychological placebo",NA,NA,0,2,"msd","co","cy-bocs","cr","post","14",13.3,8.4,40,17.2,8.8,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.7","4.5999999999999996",49,"25.3","4.5",22,"9","5",2011,"n","FB","12","N America","child",12,"0.63","0","0","com","adol","Some concerns","High risk","Some concerns","Low risk","Low risk","2","Piacentini, J., Bergman, R. L., Chang, S., Langley, A., Peris, T., Wood, J. J., & McCracken, J. (2011). Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry, 50(11), 1149-1161. ",2,"Piacentini_2011_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA",0.451566019215729,0.292681159615566,NA,NA,NA,NA,NA,NA
"82",82,"POST,2004","cbt","pill placebo","cbt","pill placebo",1,3,"msd","itt","cy-bocs","cr","post","12",14,9.5,28,21.5,5.4,28,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26","4.5999999999999996",28,"25.2","3.3",28,"3","7",2004,"n","ind","14","N America","child",12,"0.5","NR","NR","com","adol and child","Some concerns","Some concerns","Some concerns","Low risk","Some concerns","2","Team, P. O. T. S. P. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. Jama, 292(16), 1969-1976.",2,"POST_2004_msd_cy-bocs_post_12_cr_cbt_pillplacebo_cbt_pillplacebo",0.957091177851022,0.282560552134661,NA,NA,NA,NA,NA,NA
"83",83,"Rezvan,2013","other psy","no treatment",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","8",24.08,3.5,12,28.83,3.21,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"29.91","3.2",12,"29.16","2.69",12,"0","0",2012,"n","oth","8","oth","child",10,"1","0","0","clin","child","Some concerns","Some concerns","Low risk","Some concerns","Some concerns","2","Rezvan, S., Bahrami, F., Abedi, M., Macleod, C., Doost, H. T. N., & Ghasemi, V. (2013). A preliminary study on the effects of attachment-based intervention on pediatric obsessive-compulsive disorder. International journal of preventive medicine, 4(1), 78. ",2,"Rezvan_2013_msd_cy-bocs_post_8_cr_otherpsy_notreatment_NA_NA",1.36570182595744,0.456452463654361,NA,NA,NA,NA,NA,NA
"84",84,"Rezvan,2013","other psy","no treatment",NA,NA,0,2,"msd","itt","cy-bocs","cr","fu1","12",22.83,2.75,12,29.33,2.74,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"29.91","3.2",12,"29.16","2.69",12,"0","0",2012,"n","oth","8","oth","child",10,"1","0","0","clin","child","Some concerns","Some concerns","Low risk","Some concerns","Some concerns","2","Rezvan, S., Bahrami, F., Abedi, M., Macleod, C., Doost, H. T. N., & Ghasemi, V. (2013). A preliminary study on the effects of attachment-based intervention on pediatric obsessive-compulsive disorder. International journal of preventive medicine, 4(1), 78. ",2,"Rezvan_2013_msd_cy-bocs_fu1_12_cr_otherpsy_notreatment_NA_NA",2.28628475695497,0.532430146999802,NA,NA,NA,NA,NA,NA
"85",85,"Rupp,2019","other psy","wl",NA,NA,0,2,"msd","co","ybocs","cr","post","2",20.4,6.71,20,23.6,2.39,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.5","3.82",20,"23.85","2.74",20,"2","1",2019,"n","ind","4","eu","adul",31,"0.57999999999999996","0.36","0.52","com","adul","Low risk","High risk","Some concerns","Low risk","Low risk","2","Rupp, C., Jürgens, C., Doebler, P., Andor, F., & Buhlmann, U. (2019). A randomized waitlist-controlled trial comparing detached mindfulness and cognitive restructuring in obsessive-compulsive disorder. PLoS One, 14(3), e0213895.",2,"Rupp_2019_msd_ybocs_post_2_cr_otherpsy_wl_NA_NA",0.622717077319245,0.324107554694402,NA,NA,NA,NA,NA,NA
"86",86,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","27",17.8,8.4,20,20.8,7.8,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.8","3.7",23,"25.1","5.0999999999999996",23,"3","3",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_ybocs_post_27_cr_erp_psychologicalplacebo_NA_NA",0.362763295063727,0.318923703677107,NA,NA,NA,NA,NA,NA
"87",87,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","oci-r","sr","post","27",26.8,15.3,20,30.9,13.4,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"31.5","12.7",23,"30.3","11.9",23,"3","3",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_oci-r_post_27_sr_erp_psychologicalplacebo_NA_NA",0.279426189467755,0.317830073337861,NA,NA,NA,NA,NA,NA
"88",88,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","d-ybocs","cr","post","27",15.5,7.1,20,17.1,7.5,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"20.7","3.8",23,"20.3","4.7",23,"3","3",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_d-ybocs_post_27_cr_erp_psychologicalplacebo_NA_NA",0.214742971778394,0.317175089662388,NA,NA,NA,NA,NA,NA
"89",89,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu1","31",18.7,8.2,18,20.7,5.4,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.8","3.7",23,"25.1","5.0999999999999996",23,"5","6",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_ybocs_fu1_31_cr_erp_psychologicalplacebo_NA_NA",0.279808730880209,0.339927342280216,NA,NA,NA,NA,NA,NA
"90",90,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","oci-r","sr","fu1","31",29.3,12.9,18,31.1,14.4,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"31.5","12.7",23,"30.3","11.9",23,"5","6",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_oci-r_fu1_31_sr_erp_psychologicalplacebo_NA_NA",0.128868294416469,0.338566949749972,NA,NA,NA,NA,NA,NA
"91",91,"Russell,2013","erp","psychological placebo",NA,NA,0,2,"msd","co","d-ybocs","cr","fu1","31",15.8,7,18,17,5.9,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"20.7","3.8",23,"20.3","4.7",23,"5","6",2013,"y","ind","17","uk","adul",27,"0.24","NR","NR","oth","adul and adol","Low risk","High risk","Some concerns","Low risk","Some concerns","2","Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708. ",2,"Russell_2013_msd_d-ybocs_fu1_31_cr_erp_psychologicalplacebo_NA_NA",0.180665712765469,0.338921060802838,NA,NA,NA,NA,NA,NA
"92",92,"Russman Block,2023","erp","psychological placebo","a","psychological placebo",0,2,"msd","co","ybocs","cr","post","12",13.46,9.62,27,21.73,8.49,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"26.19","5.34",27,"27.61","5.04",27,"NR","NR",2023,"n","ind","12","N America","adol",16,"0.67","0.67","0.56000000000000005","com","adol","High risk","High risk","High risk","Low risk","Some concerns","2","Russman Block, S., Norman, L. J., Zhang, X., Mannella, K. A., Yang, H., Angstadt, M., . . . Fitzgerald, K. D. (2023). Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial. Am J Psychiatry, 180(1), 89-99. doi:10.1176/appi.ajp.21111173",2,"RussmanBlock_2023_msd_ybocs_post_12_cr_erp_psychologicalplacebo_a_psychologicalplacebo",0.898324190839432,0.28595026383483,NA,NA,NA,NA,NA,NA
"93",93,"Russman Block,2023","erp","psychological placebo","b","psychological placebo",0,2,"msd","co","ybocs","cr","post","12",11.62,6.24,31,23.08,7.29,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.76","5.15",31,"26.9","4.68",31,"NR","NR",2023,"n","ind","12","N America","adul",32,"0.52","0.45","0.42","com","adul","High risk","High risk","High risk","Low risk","Some concerns","2","Russman Block, S., Norman, L. J., Zhang, X., Mannella, K. A., Yang, H., Angstadt, M., . . . Fitzgerald, K. D. (2023). Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial. Am J Psychiatry, 180(1), 89-99. doi:10.1176/appi.ajp.21111173",2,"RussmanBlock_2023_msd_ybocs_post_12_cr_erp_psychologicalplacebo_b_psychologicalplacebo",1.66773503839532,0.295838088306778,NA,NA,NA,NA,NA,NA
"94",94,"Schneider,2015","ct","wl",NA,NA,0,2,"other stat","itt","ybocs","sr","post","4",NA,NA,34,NA,NA,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.24,0.25,NA,NA,NA,NA,34,NA,NA,31,"6","2",2014,"n","ush","8","eu","adul",37,"0.57999999999999996","0.94","0.97","com","adul","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","",2,"Schneider_2015_otherstat_ybocs_post_4_sr_ct_wl_NA_NA",0.24,0.25,NA,NA,NA,NA,NA,NA
"95",95,"Schneider,2015","ct","wl",NA,NA,0,2,"other stat","itt","oci-r","sr","post","4",NA,NA,34,NA,NA,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.08,0.25,NA,NA,NA,NA,34,NA,NA,31,"6","2",2014,"n","ush","8","eu","adul",37,"0.57999999999999996","0.94","0.97","com","adul","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","",2,"Schneider_2015_otherstat_oci-r_post_4_sr_ct_wl_NA_NA",0.08,0.25,NA,NA,NA,NA,NA,NA
"96",96,"Storch,2011","cbt","wl","cbt","wl",1,3,"msd","itt","cy-bocs","cr","post","12",11.13,10.53,16,18.53,8.11,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.38","3.61",16,"21.27","2.74",15,"2","0",2011,"n","FB","14","N America","child",11,"0.39","0.56000000000000005","0.53","com","adol and child","High risk","Low risk","Some concerns","Low risk","Some concerns","2","Storch, E. A., Caporino, N. E., Morgan, J. R., Lewin, A. B., Rojas, A., Brauer, L., . . . Murphy, T. K. (2011). Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res, 189(3), 407-412. ",2,"Storch_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt_wl",0.763488890325518,0.372932893090299,NA,NA,NA,NA,NA,NA
"97",97,"Twohig,2010","third-wave","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","post","9",12.76,8.35,36,18.67,5.68,33,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.22","4.8",41,"25.4","5.26",38,"0","0",2010,"n","ind","8","N America","adul",37,"0.66","0.34","0.44","com","adul","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Twohig, M. P., Hayes, S. C., Plumb, J. C., Pruitt, L. D., Collins, A. B., Hazlett-Stevens, H., & Woidneck, M. R. (2010). A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult Clin Psychol, 78(5), 705-716. ",2,"Twohig_2010_msd_ybocs_post_9_cr_third-wave_psychologicalplacebo_NA_NA",0.811680095239471,0.250926319422457,NA,NA,NA,NA,NA,NA
"98",98,"Twohig,2010","third-wave","psychological placebo",NA,NA,0,2,"msd","itt","ybocs","cr","fu1","22",11.79,8.97,33,16.23,7.46,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.22","4.8",41,"25.4","526",38,"0","0",2010,"n","ind","8","N America","adul",37,"0.66","0.34","0.44","com","adul","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Twohig, M. P., Hayes, S. C., Plumb, J. C., Pruitt, L. D., Collins, A. B., Hazlett-Stevens, H., & Woidneck, M. R. (2010). A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult Clin Psychol, 78(5), 705-716. ",2,"Twohig_2010_msd_ybocs_fu1_22_cr_third-wave_psychologicalplacebo_NA_NA",0.53011343977644,0.254579819440372,NA,NA,NA,NA,NA,NA
"99",99,"van-Balkom,1998","ct","wl","ct","wl",1,3,"msd","co","ybocs","cr","post","8",21.5,10.4,25,26.4,6.8,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25.3","6.6",25,"26.8","6.4",18,"0","2",1998,"NR","ind","6","eu","adul",35,"0.63","0.16","0.06","com","adul","Some concerns","Some concerns","Low risk","Low risk","Some concerns","2","van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499. ",2,"van-Balkom_1998_msd_ybocs_post_8_cr_ct_wl_ct_wl",0.523213918715041,0.325532686811348,NA,NA,NA,NA,NA,NA
"100",100,"van-Balkom,1998","ct","wl","ct","wl",1,3,"msd","co","padua","sr","post","8",61.2,25.5,25,68.6,34.6,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"71.900000000000006","21",25,"67.099999999999994","31",18,"0","2",1998,"NR","ind","6","eu","adul",35,"0.63","0.16","0.06","com","adul","Some concerns","Some concerns","Low risk","Low risk","Some concerns","2","van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499. ",2,"van-Balkom_1998_msd_padua_post_8_sr_ct_wl_ct_wl",0.247367670138564,0.321365797684674,NA,NA,NA,NA,NA,NA
"101",101,"van-Balkom,1998","erp","wl","erp","wl",1,3,"msd","co","ybocs","cr","post","8",18.6,8.5,20,26.4,6.8,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"25","7.9",22,"26.8","6.4",18,"2","2",1998,"NR","ind","6","eu","adul",35,"0.54","0.16","0.06","com","adul","Some concerns","Some concerns","Low risk","Low risk","Some concerns","2","van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499. ",2,"van-Balkom_1998_msd_ybocs_post_8_cr_erp_wl_erp_wl",0.978300513863116,0.355533041102382,NA,NA,NA,NA,NA,NA
"102",102,"van-Balkom,1998","erp","wl","erp","wl",1,3,"msd","co","padua","sr","post","8",58,23.3,20,68.6,34.6,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"65.2","18.7",22,"67.099999999999994","31",18,"2","2",1998,"NR","ind","6","eu","adul",35,"0.54","0.16","0.06","com","adul","Some concerns","Some concerns","Low risk","Low risk","Some concerns","2","van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499. ",2,"van-Balkom_1998_msd_padua_post_8_sr_erp_wl_erp_wl",0.359422151403439,0.338196257601311,NA,NA,NA,NA,NA,NA
"103",103,"Vogel,2014","erp","wl","erp(vct)","wl",1,3,"msd","itt","ybocs","cr","post","12",11.5,4.8,10,23.4,4.8,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.2","4.3",10,"23.4","2.8",10,"0","2",2014,"n","oth","12","eu","adul",35,"0.55000000000000004","NR","NR","clin","adul","Some concerns","some concerns","High risk","Low risk","Some concerns","2","Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168. ",2,"Vogel_2014_msd_ybocs_post_12_cr_erp_wl_erp(vct)_wl",2.37441314553991,0.594690410236938,NA,NA,NA,NA,NA,NA
"104",104,"Vogel,2014","erp","wl","erp(vct)","wl",1,3,"msd","itt","voci","sr","post","12",28.1,21.5,10,65.5,22.3,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"60.8","30.2",10,"63.7","23.1",10,"0","2",2014,"n","oth","12","eu","adul",35,"0.55000000000000004","NR","NR","clin","adul","Some concerns","some concerns","High risk","Low risk","Some concerns","2","Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168. ",2,"Vogel_2014_msd_voci_post_12_sr_erp_wl_erp(vct)_wl",1.63533082177066,0.522385880703309,NA,NA,NA,NA,NA,NA
"105",105,"Vogel,2014","erp","wl","erp(ush)","wl",1,3,"msd","itt","ybocs","cr","post","12",22.7,5.6,10,23.4,4.8,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.1","2.7",10,"23.4","2.8",10,"1","2",2014,"n","ush","12","eu","adul",35,"0.6","NR","NR","clin","adul","Some concerns","Low risk","Some concerns","Low risk","some concerns","2","Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168. ",2,"Vogel_2014_msd_ybocs_post_12_cr_erp_wl_erp(ush)_wl",0.128547653060334,0.447716838690549,NA,NA,NA,NA,NA,NA
"106",106,"Vogel,2014","erp","wl","erp(ush)","wl",1,3,"msd","itt","voci","sr","post","12",57.4,40.1,10,65.5,22.3,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"64.900000000000006","32",10,"63.7","23.1",10,"1","2",2014,"n","ush","12","eu","adul",35,"0.6","NR","NR","clin","adul","Some concerns","Low risk","Some concerns","Low risk","some concerns","2","Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168. ",2,"Vogel_2014_msd_voci_post_12_sr_erp_wl_erp(ush)_wl",0.239107712945912,0.448952347394822,NA,NA,NA,NA,NA,NA
"107",107,"Whittal,2010","ct","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","12",6.43,4.77,37,9.1,6.48,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"18.03","6.29",37,"17.73","7.73",30,"0","0",2009,"n","ind","12","N America","adul",32,"0.46","0.52","0.52","com","adul","Some concerns","NR","NR","Low risk","NR","NR","Whittal, M. L., Woody, S. R., McLean, P. D., Rachman, S. J., & Robichaud, M. (2010). Treatment of obsessions: a randomized controlled trial. Behav Res Ther, 48(4), 295-303. ",NA,"Whittal_2010_msd_ybocs_post_12_cr_ct_psychologicalplacebo_NA_NA",0.471445153890758,0.249114679811849,NA,NA,NA,NA,NA,NA
"108",108,"Whittal,2010","ct","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu1","26",8.68,6.83,37,8.93,7.78,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"18.03","6.29",37,"17.73","7.73",30,"3","3",2009,"n","ind","12","N America","adul",32,"0.46","0.52","0.52","com","adul","Some concerns","NR","NR","Low risk","NR","NR","Whittal, M. L., Woody, S. R., McLean, P. D., Rachman, S. J., & Robichaud, M. (2010). Treatment of obsessions: a randomized controlled trial. Behav Res Ther, 48(4), 295-303. ",NA,"Whittal_2010_msd_ybocs_fu1_26_cr_ct_psychologicalplacebo_NA_NA",0.0339933131245617,0.245701418656711,NA,NA,NA,NA,NA,NA
"109",109,"Whittal,2010","ct","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu2","52",8,6.54,37,9.33,7.76,30,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"18.03","6.29",37,"17.73","7.73",30,"3","6",2009,"n","ind","12","N America","adul",32,"0.46","0.52","0.52","com","adul","Some concerns","NR","NR","Low risk","NR","NR","Whittal, M. L., Woody, S. R., McLean, P. D., Rachman, S. J., & Robichaud, M. (2010). Treatment of obsessions: a randomized controlled trial. Behav Res Ther, 48(4), 295-303. ",NA,"Whittal_2010_msd_ybocs_fu2_52_cr_ct_psychologicalplacebo_NA_NA",0.184888085666631,0.246214288495274,NA,NA,NA,NA,NA,NA
"110",110,"Wilhelm,2009","ct","wl",NA,NA,0,2,"change","itt","ybocs","cr","post","12",NA,NA,NA,NA,NA,NA,-9.92,0.46,6.7,3.8,12,12,NA,NA,NA,NA,NA,NA,NA,NA,"26.5","4.7",15,"24.6","4.7",14,"3","2",2009,"n","ind","12","N America","adul",33,"0.52","0.48","0.48","com","adul","High risk","Low risk","Some concerns","Low risk","Some concerns","2","Wilhelm, S., Steketee, G., Fama, J. M., Buhlmann, U., Teachman, B. A., & Golan, E. (2009). Modular cognitive therapy for obsessive-compulsive disorder: A wait-list controlled trial. Journal of Cognitive Psychotherapy, 23(4), 294-305. ",2,"Wilhelm_2009_change_ybocs_post_12_cr_ct_wl_NA_NA",1.84007366854321,0.492274435548278,NA,NA,NA,NA,NA,NA
"111",111,"Williams,2010","cbt","wl",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","12",12.09,7.46,11,19.6,6.4,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.09","4.04",11,"21.05","5.82",10,"1","1",2010,"n","ind","10","uk","adol",14,"0.38","0.33","0.33","clin","child and adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Williams, T. I., Salkovskis, P. M., Forrester, L., Turner, S., White, H., & Allsopp, M. A. (2010). A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents. Eur Child Adolesc Psychiatry, 19(5), 449-456. ",2,"Williams_2010_msd_cy-bocs_post_12_cr_cbt_wl_NA_NA",1.0331906936259,0.467426465165024,NA,NA,NA,NA,NA,NA
"112",112,"Williams,2010","cbt","wl",NA,NA,0,2,"msd","itt","oci","sr","post","12",45,27.5,11,60.3,30.4,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"59.3","27.5",11,"73.55","26.1",10,"1","1",2010,"n","ind","10","uk","adol",14,"0.38","0.33","0.33","clin","child and adol","Low risk","Low risk","Some concerns","Low risk","Some concerns","2","Williams, T. I., Salkovskis, P. M., Forrester, L., Turner, S., White, H., & Allsopp, M. A. (2010). A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents. Eur Child Adolesc Psychiatry, 19(5), 449-456. ",2,"Williams_2010_msd_oci_post_12_sr_cbt_wl_NA_NA",0.508060037278917,0.444497184364503,NA,NA,NA,NA,NA,NA
"113",113,"Wolters,2016","cbt","wl",NA,NA,0,2,"msd","itt","cy-bocs","cr","post","8",19.84,4.92,19,24.27,6.12,22,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"24.21","3.61",20,"24.59","3.98",24,"1","2",2016,"y","ind","8","eu","child",12.5,"0.61","0","0","clin","child and adol","Some concerns","Low risk","some concerns","Low risk","Some concerns","2","Wolters, L. H., de Haan, E., Hogendoorn, S. M., Boer, F., & Prins, P. J. M. (2016). Severe pediatric obsessive compulsive disorder and co-morbid autistic symptoms: Effectiveness of cognitive behavioral therapy. Journal of Obsessive-Compulsive and Related Disorders, 10, 69-77. ",2,"Wolters_2016_msd_cy-bocs_post_8_cr_cbt_wl_NA_NA",0.776008621491588,0.325150186567715,NA,NA,NA,NA,NA,NA
"114",114,"Wootton,2013","cbt","wl","cbt(bibli)","wl",1,3,"msd","itt","ybocs","cr","post","8",13.27,5.23,20,20.49,5.07,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.8","5.0999999999999996",20,"21.06","5.1100000000000003",17,"5","5",2013,"n","gsh","4.33","au","adul",37,"0.68","0.5","0.77","com","adul","Low risk","Low risk","Some concerns","High risk","High risk","2","Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384. ",2,"Wootton_2013_msd_ybocs_post_8_cr_cbt_wl_cbt(bibli)_wl",1.36969646806253,0.367840487509281,NA,NA,NA,NA,NA,NA
"115",115,"Wootton,2013","cbt","wl","cbt(bibli)","wl",1,3,"msd","itt","docs","sr","post","8",8.05,4.25,20,10.66,4.04,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"12.5","3.49",20,"11.94","3.5",17,"5","3",2013,"n","gsh","4","au","adul",37,"0.68","0.5","0.77","com","adul","Low risk","Low risk","Some concerns","High risk","High risk","2","Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384. ",2,"Wootton_2013_msd_docs_post_8_sr_cbt_wl_cbt(bibli)_wl",0.614554561829371,0.337868207450282,NA,NA,NA,NA,NA,NA
"116",116,"Wootton,2013","cbt","wl","cbt(internet)","wl",1,3,"msd","itt","ybocs","cr","post","8",12.38,5.27,15,20.49,5.07,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"23.53","5.07",15,"21.06","5.1100000000000003",17,"6","5",2013,"n","gsh","4","au","adul",39,"0.78","0.6","0.77","com","adul","Low risk","Low risk","Some concerns","High risk","High risk","2","Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384. ",2,"Wootton_2013_msd_ybocs_post_8_cr_cbt_wl_cbt(internet)_wl",1.53080772654583,0.404998478259772,NA,NA,NA,NA,NA,NA
"117",117,"Wootton,2013","cbt","wl","cbt(internet)","wl",1,3,"msd","itt","docs","sr","post","8",7.93,4.38,15,10.66,4.04,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"12.07","3.49",15,"11.94","3.5",17,"7","3",2013,"n","gsh","4","au","adul",39,"0.78","0.6","0.77","com","adul","Low risk","Low risk","Some concerns","High risk","High risk","2","Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384. ",2,"Wootton_2013_msd_docs_post_8_sr_cbt_wl_cbt(internet)_wl",0.633298071576663,0.363435260411514,NA,NA,NA,NA,NA,NA
"118",118,"Zejuan-Fu,2016","cbt","cau",NA,NA,0,2,"msd","co","ybocs","cr","post","NR",20.68,2.83,50,25.98,3.26,50,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"29.16","4.79",50,"29.22","5.03",50,"0","0",2016,"n","oth","NR","oth","adul",33,"0.55000000000000004","0.56000000000000005","0.54","clin","adul","Some concerns","Some concerns","Low risk","Some concerns","Some concerns","2","FU Zejuan, XIE Hailing. Effect evaluation of cognitive behavior intervention therapy in improving psychological status and quality of life in patients with obsessive-compulsive disorder[J]. Journal of Clinical Medicine in Practice, 2016, (8): 17-20. doi: 10.7619/jcmp.201608006",2,"Zejuan-Fu_2016_msd_ybocs_post_NR_cr_cbt_cau_NA_NA",1.72291423332595,0.234675462372427,NA,NA,NA,NA,NA,NA
"119",119,"Zhang,2021","third-wave","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","post","10",13.54,6.1,28,14.97,4,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.18","3.3",28,"19.79","3.7",29,"14","11",2021,"n","grp","11","oth","adul",29,"0.32","0","0","clin","adul","High risk","High risk","Some concerns","Low risk","Low risk","2","Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021). Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry, 12. ",2,"Zhang_2021_msd_ybocs_post_10_cr_third-wave_psychologicalplacebo_NA_NA",0.274437550684144,0.266225825230024,NA,NA,NA,NA,NA,NA
"120",120,"Zhang,2021","third-wave","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu1","14",13.36,4.7,28,12.79,4.8,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.18","3.3",28,"19.79","3.7",29,"14","11",2021,"n","grp","11","oth","adul",29,"0.32","0","0","clin","adul","High risk","High risk","Some concerns","Low risk","Low risk","2","Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021). Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry, 12. ",2,"Zhang_2021_msd_ybocs_fu1_14_cr_third-wave_psychologicalplacebo_NA_NA",-0.118326966166115,0.265185402706212,NA,NA,NA,NA,NA,NA
"121",121,"Zhang,2021","third-wave","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu2","22",14.36,4.2,28,13.57,4.7,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.18","3.3",28,"19.79","3.7",29,"14","11",2021,"n","grp","11","oth","adul",29,"0.32","0","0","clin","adul","High risk","High risk","Some concerns","Low risk","Low risk","2","Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021). Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry, 12. ",2,"Zhang_2021_msd_ybocs_fu2_22_cr_third-wave_psychologicalplacebo_NA_NA",-0.174642796902956,0.265465765285237,NA,NA,NA,NA,NA,NA
"122",122,"Zhang,2021","third-wave","psychological placebo",NA,NA,0,2,"msd","co","ybocs","cr","fu3","34",13.66,4.5,28,11.74,6,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"21.18","3.3",28,"19.79","3.7",29,"14","11",2021,"n","grp","11","oth","adul",29,"0.32","0","0","clin","adul","High risk","High risk","Some concerns","Low risk","Low risk","2","Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021). Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry, 12. ",2,"Zhang_2021_msd_ybocs_fu3_34_cr_third-wave_psychologicalplacebo_NA_NA",-0.356173764933427,0.267097313864337,NA,NA,NA,NA,NA,NA
